MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 205687-03-2
MCE 国际站:Dihydrocapsiate
产品活性:Dihydrocapsiate 作为二氢 capsinoid 家族的化合物,是一种口服活性 TRPV1 激动剂。Dihydrocapsiate 可用于代谢疾病的研究。
研究领域:Membrane Transporter/Ion Channel | Neuronal Signaling
作用靶点:TRP Channel
结构分类:酚类 | 单酚类 | 结构分类
来源:植物 | 茄科 | 辣椒
In Vitro: Dihydrocapsiate (10, 25 and 50 μM; 48 hours; human preadipocytes) does not affect cell viability.
Dihydrocapsiate (10 and 20 μM; 8 days; mature adipocytes) markedly decreases the expression levels of other adipogenic markers (such as SREBP1, FABP4, PLIN1, ADIPOQ and LEPTIN) and inflammatory markers (MCP1 and TNFα), whereas it enhances the expression levels of PGC1α (master regulator of mitochondrial biogenesis) and TBX1 (marker of “brite” cell) .
Dihydrocapsiate (25~200 μM; RAW 264.7 cells) prevents NO release and intracellular ROS generation.
In Vivo: Dihydrocapsiate (2 and 10 mg/kg; p.o.) improves morphometric parameters and insulin levels, prevents high fat diet (HFD)-induced adipocyte size and enhances energy expenditure-related genes in WAT, alleviates HFD-induced hepatic steatosis, prevents HFD-induced fat deposition and enhances mitochondrial biogenesis genes in BAT and improves intestinal morphology and modulates SCFA availability.
相关产品:Natural Product Library Plus | Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Membrane Transporter/Ion Channel Compound Library | Neuronal Signaling Compound Library | Natural Product Library | FDA-Approved Drug Library | Drug Repurposing Compound Library | Phenols Library | Orally Active Compound Library | FDA Approved & Pharmacopeial Drug Library | Mechanoreceptors Compound Library | Plant-Sourced Natural Product Library | Human Metabolite Library | Pain-Related Compound Library | Off-patent Drug Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Bisandrographolide C | TRPV1 activator-2 | SB-705498 | AMTB hydrochloride | ABT-239 | AS1269574 | Tivanisiran | RN-1747 | CEDAEVFKDSMVPGEK | Asivatrep | TRPV4 agonist-1 | GsMTx4 TFA | TRPC3/6-IN-2 | SET2 | (E)-4-Oxo-2-nonenal | 1-Stearoyl-2-arachidonoyl-sn-glycerol | Podocarpic acid | M8-B | Pregnenolone monosulfate sodium | TRPC5 modulator-1 | Capsiate | Diisopropyl adipate | FEMA 4809 | Capsazepine | JT010 | Umbellulone | ML-SI1 | TRPC5-IN-4 | EIPA hydrochloride | GSK2193874
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。